Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| erythrocyte | 5 studies | 30% ± 12% | |
| epithelial cell | 3 studies | 28% ± 11% | |
| erythroblast | 3 studies | 51% ± 16% | |
| T cell | 3 studies | 19% ± 4% | |
| CD4-positive, alpha-beta T cell | 3 studies | 33% ± 6% |
Insufficient scRNA-seq data for expression of CCNB2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 98% | 1113.23 | 1764 / 1809 | 91% | 33.95 | 430 / 472 |
| intestine | 77% | 423.40 | 747 / 966 | 97% | 51.69 | 511 / 527 |
| lung | 83% | 194.95 | 480 / 578 | 88% | 40.59 | 1020 / 1155 |
| stomach | 58% | 236.60 | 207 / 359 | 98% | 47.14 | 279 / 286 |
| uterus | 57% | 84.31 | 97 / 170 | 98% | 72.60 | 449 / 459 |
| esophagus | 54% | 424.51 | 782 / 1445 | 99% | 56.98 | 181 / 183 |
| bladder | 57% | 68.90 | 12 / 21 | 95% | 51.93 | 478 / 504 |
| breast | 50% | 77.68 | 228 / 459 | 88% | 33.23 | 980 / 1118 |
| ovary | 32% | 57.77 | 57 / 180 | 99% | 49.79 | 424 / 430 |
| prostate | 89% | 165.16 | 218 / 245 | 34% | 5.85 | 173 / 502 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 64.40 | 29 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 74.78 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 24.05 | 1 / 1 |
| spleen | 98% | 537.91 | 237 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 89% | 164.42 | 1190 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 11% | 14.43 | 36 / 328 | 72% | 18.89 | 129 / 178 |
| peripheral blood | 76% | 1289.86 | 707 / 929 | 0% | 0 | 0 / 0 |
| thymus | 49% | 66.64 | 317 / 653 | 18% | 13.88 | 110 / 605 |
| kidney | 54% | 93.46 | 48 / 89 | 12% | 2.45 | 111 / 901 |
| liver | 15% | 40.86 | 34 / 226 | 49% | 10.84 | 198 / 406 |
| adrenal gland | 37% | 63.19 | 95 / 258 | 15% | 5.07 | 35 / 230 |
| adipose | 45% | 73.74 | 546 / 1204 | 0% | 0 | 0 / 0 |
| brain | 5% | 5.63 | 124 / 2642 | 39% | 13.46 | 274 / 705 |
| eye | 0% | 0 | 0 / 0 | 14% | 1.83 | 11 / 80 |
| heart | 12% | 18.44 | 107 / 861 | 0% | 0 | 0 / 0 |
| muscle | 2% | 2.41 | 16 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043029 | Biological process | T cell homeostasis |
| GO_0001701 | Biological process | in utero embryonic development |
| GO_0000079 | Biological process | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO_0007057 | Biological process | spindle assembly involved in female meiosis I |
| GO_0051301 | Biological process | cell division |
| GO_0048538 | Biological process | thymus development |
| GO_0008315 | Biological process | G2/MI transition of meiotic cell cycle |
| GO_0040008 | Biological process | regulation of growth |
| GO_0044772 | Biological process | mitotic cell cycle phase transition |
| GO_0016020 | Cellular component | membrane |
| GO_0005813 | Cellular component | centrosome |
| GO_0000307 | Cellular component | cyclin-dependent protein kinase holoenzyme complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0015630 | Cellular component | microtubule cytoskeleton |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0016538 | Molecular function | cyclin-dependent protein serine/threonine kinase regulator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CCNB2 |
| Protein name | G2/mitotic-specific cyclin-B2 |
| Synonyms | CCNB2V |
| Description | FUNCTION: Essential for the control of the cell cycle at the G2/M (mitosis) transition. FUNCTION: Essential for the control of the cell cycle at the G2/M (mitosis) transition. . FUNCTION: Essential for the control of the cell cycle at the G2/M (mitosis) transition. . |
| Accessions | H0YMP3 ENST00000288207.7 O95067 ENST00000559622.5 ENST00000621385.1 H1UBN3 |
